Daslemia 70 Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Dasatinib (70mg)
Overview Daslemia 70 Tablet
Chronic myeloid leukemia (CML) is treated with Daslemia 70 Tablet, particularly in patients unresponsive to or intolerant of other leukemia therapies. Daslemia 70 Tablet may be taken with or without food, but consistent daily timing optimizes efficacy. Dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your prescribed regimen; incorrect usage or overdose can have severe consequences. Therapeutic effects might not be apparent for weeks or months; discontinue only under your doctor's direction. Common side effects include nausea, vomiting, stomach pain, and skin rash. Increased heart rate and blood pressure fluctuations (high or low) may occur; consult your doctor if these arise. Regular blood pressure monitoring may be necessary. Avoid antacids within two hours of taking this medication. Daslemia 70 Tablet can lower blood cell counts, increasing infection risk; regular blood tests are crucial. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or visual disturbances develop.
Uses of Daslemia 70 Tablet
Chronic myelogenous leukemia, a type of blood malignancy.
Major Benefits of Daslemia 70 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Daslemia 70 Tablet. Ingest the tablet whole; avoid crushing, chewing, or breaking it. While Daslemia 70 Tablet can be taken with or without food, consistent timing is recommended.
Common Side effects of Daslemia 70 Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Daslemia 70 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Daslemia 70 Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Daslemia 70 Tablets can be administered with or without food, although consistent timing is recommended.
How Daslemia 70 Tablet works:
Oncasin 70 is an anti-neoplastic agent. Its mechanism of action involves inhibiting the activity of a defective protein responsible for triggering cancerous cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Daslemia 70 Tablet with alcohol is undefined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Daslemia 70 Tablet is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Daslemia 70 Tablet are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Daslemia 70 Tablet side effects. Exercise caution while driving if you experience dizziness or blurred vision after taking Daslemia 70 Tablet.
KidneySAFE IF PRESCRIBED
Individuals with kidney disease can likely use Daslemia 70 Tablet safely. Available evidence indicates dose modification may be unnecessary, but physician consultation is advised.
LiverSAFE IF PRESCRIBED
Daslemia 70 Tablet poses no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Daslemia 70 Tablet :
Omit any missed Daslemia 70 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Daslemia 70 Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Drugs |
| Actions | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently